Peptable

Comparison

PT-141 vs Selank

Also see:

PT-141Selank

Function

While PT-141 is FDA-approved for treatment of hypoactive sexual desire disorder in premenopausal women and is studied for sexual dysfunction in other populations, increasing sexual desire via CNS melanocortin pathways42101, Selank is a peptide developed in Russia as an anxiolytic and nootropic; in animal models it reduces anxiety-like behavior and modulates immune parameters under stress39.

Mechanism

While PT-141 works as the synthetic melanocortin receptor agonist bremelanotide, an analog of α-MSH that activates central MC3R and MC4R to modulate neuronal circuits governing sexual desire and arousal3242101, Selank is a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, that combines a tuftsin fragment with a Pro-Gly-Pro motif and is reported to modulate GABAergic neurotransmission and cytokine balance while being resistant to proteolytic degradation39.

Receptor

PT-141

Melanocortin receptors, with highest functional relevance at MC4R and MC3R; also binds MC1R and MC5R3242

Selank

Not clearly established in the current dataset.

Organism or Origin

PT-141

Synthetic analog of human α-MSH derived from POMC428190

Selank

Synthetic analog of the IgG-derived tetrapeptide tuftsin39

Gene

PT-141

POMC

Selank

Not assigned in the current dataset.

Summary

Both peptides fall into a similar broad context as Neuropeptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: PT-141 is more often discussed in the realm of Reproductive health, whereas Selank is more often associated with the realm of Neurology and brain health and Immunology and inflammation. Mechanistically, both point toward Neurotransmitter modulator and Signaling modulator and converge on GPCR receptor, although the downstream emphasis is not identical. Both are synthetic in origin and their development context also differs, with PT-141 approved while Selank is approved for Research use only. PT-141 takes the form of a cyclic peptide, whereas Selank is closer to a linear peptide, PT-141 incorporates acetylation features that are not part of Selank; while their sequence patterns also diverge, with PT-141 showing protein-mimetic sequence features and Selank showing proline-rich features.

Related articles

No related articles are linked to these peptides yet.

Sources

32PT-141 (Bremelanotide): Research Applications and Quality ..., https://wheretofindpeptides.com/research/pt-141-bremelanotide-research-applications-and-quality-assessment-1
42[PDF] The Discovery and Development of Bremelanotide (PT-141), https://www.benchchem.com/pdf/The_Discovery_and_Development_of_Bremelanotide_PT_141_A_Technical_Guide.pdf
81Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC2253185/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/
101PT-141 (Bremelanotide Acetate): Clinical Overview, Uses ... - eNavvi, https://enavvi.com/insights/pt-141-bremelanotide-for-sexual-dysfunction-clinical-guide-for-physicians
39Application of thr-lys-pro-arg-pro-gly-pro peptide (selank) for ..., https://patents.google.com/patent/RU2629832C1/en